In addition, ACE2 and TMPRSS2 were expressed at higher levels in the taste buds of patients with COVID-19 than in the control group (Figure 3C), indicating that SARS-CoV-2 infection might change the relative receptor expression. The gene discussed is ACE2; the disease is COVID-19.